Ross S

The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.

Brar PS, Price RB, Ross S +2

Europe PMC2026

PreprintPsilocybin

Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial

Pagni BA, Ross S, Mennenga S +11

Europe PMC2026

Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.

Griffiths RR, Jesse R, Richards WA +4

PreprintPsilocybin

Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion

Zeifman R, Danias G, Agin-Liebes G +6

Exploring serotonergic psychedelics as a treatment for personality disorders.

Carrithers BM, Roberts DE, Weiss BM +7

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

Yaden DB, Graziosi M, Owen AM +39

Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.

Pagni BA, Zeifman RJ, Mennenga SE +6

Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.

Petridis PD, Grinband J, Agin-Liebes G +5

ArticlePsychedelics

Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review

Bouchet L, Sager Z, Yrondi A +5

Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.

Kim A, Halton B, Shah A +2

Older adults in psychedelic-assisted therapy trials: A systematic review.

Bouchet L, Sager Z, Yrondi A +5

ArticleMDMA

Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder.

Zeifman RJ, Kettner H, Ross S +4

ArticlePsychedelics

What Is in a Name? The Many Meanings of "Psychedelic".

O'Donnell KC, Roberts DE, Ching THW +8

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

Raison CL, Sanacora G, Woolley J +31

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.

Zeifman RJ, Kettner H, Pagni BA +5

Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.

Gold ND, Podrebarac SK, White LA +6

Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.

Gold ND, Mallard AJ, Hermann JC +4

Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.

Zia FZ, Baumann MH, Belouin SJ +7

Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.

O'Donnell KC, Mennenga SE, Owens LT +6

ArticleMDMA

MDMA-Assisted Psychotherapy for Borderline Personality Disorder.

Traynor JM, Roberts DE, Ross S +2

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.

Bogenschutz MP, Ross S, Bhatt S +10

If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.

Dworkin RH, Anderson BT, Andrews N +5

Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.

Ross S, Agin-Liebes G, Lo S +8

Europe PMC2021

Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.

Ross S

Europe PMC2018

Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.

Bogenschutz MP, Podrebarac SK, Duane JH +5

Europe PMC2018